Share your contact details to receive free updated sample copy/pages of the recently published edition of Endometriosis Market Report 2023.
Key Insights from Endometriosis Market Report
As per Cognitive Market Research's latest published report, the Global Endometriosis market size will be USD 3.56 Billion By 2030.
Endometriosis Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Endometriosis Market Report Description
What is Endometriosis?
Endometriosis is a gynecological disorder that occurs when endometriosis tissues, which normally line the uterus, spread beyond and outside the uterus, or on the ovaries and fallopian tubes. Endometriosis is characterized by painful intercourse and painful menstrual or menstrual irregularities.
Base Year | 2022 |
Historical Data Time Period | 2018-2022 |
Forecast Period | 2023-2030 |
Report Edition | 7th Edition (2023) |
Last Update | Last Updated In March 2023 |
Next Report Edition | June 2023 (Pre-Booking Available) |
Market Forecast/Projection Time Period | 2023-2030 |
Report Format | PDF | PPT | Excel | Word | Bi |
Report ID | CMR512891 |
Report scope is customizable as we have a huge database of Endometriosis industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
What is Driving Endometriosis Industry Growth?
Increasing awareness about endometriosis and starting new awareness projects for endometriosis is the major factor expected to drive the growth of the endometriosis market. However, the COVID-19 outbreak is projected to negative impact on the endometriosis market. Furthermore, increasing funding by governments for endometriosis research and development activities is anticipated to the growth opportunities for the endometriosis market during the forecast period.
Endometriosis Market Report 2023 (Global Edition) Table of Content differs according to the user License selection. Current Displayed TOC is for the Single User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report. Specific section/s of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
- 1.1 Global Endometriosis Industry Introduction
- 1.2 Objectives of the Study
- 1.3 USP of the Report
- 1.4 Who is this report for?
- 1.5 Designing of Market Scope
- 1.5.1 Endometriosis Market Segmentation
- 1.5.1 Endometriosis Market Regional Fragmentation
- 1.5.1 Endometriosis Market Players
- 1.6 Report Duration
- 1.7 List of Stakeholders
- 2.1 Endometriosis Market Report 2023 Research Methodology
- 2.2 Systematic Research Approach
- 2.2.1 Primary Research
- 2.2.1.1 Key Data from Primary
- 2.2.1.2 Primary Interviews with Experts
- 2.2.1.3 Key Industry Insights
- 2.2.1.4 Questionnaire
At Cognitive Market Research, we have designed questionnaire focused on Endometriosis Market for the statistical study. This questionnaire is the key part of our research methodology which is shared with number of Endometriosis industry experts of entire value chain, located across the globe. This study help us to gather accurate quantitative and qualitative data for the final report.
- 2.2.1.5 Breakdown of Primaries
- 2.2.2 Secondary Research
- 2.2.2.1 Key Data from Secondary
- 2.2.2.2 Paid Sources
- 2.2.2.3 Public Sources
- 2.2.1 Primary Research
- 2.3 Market Size Estimation
- 2.3.1 Top-Down Approach
- 2.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 2.3.1 Bottom-UP Approach
- 2.3.1.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 2.3.1 Top-Down Approach
- 2.4 Market Breakdown and Data Triangulation
- 2.5 Research Assumptions
- 3.1 Global Endometriosis Market Size 2018 – 2030, (USD Million)
- 3.2 Global Endometriosis Value, Absolute & Opportunity Analysis
- 3.3 Global Endometriosis Market Y-o-Y Growth Rate Projection by Region (2023 - 2030)
- 3.4 Global Endometriosis Market Statistics 2022: Snapshot
- 4.1 Endometriosis Introduction
- 4.2 Global Endometriosis Market Statistics by Regions (2018-2030)
- 4.2.1 North America Endometriosis Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.2 Europe Endometriosis Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.3 Asia Pacific Endometriosis Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.4 Latin America Endometriosis Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.5 Middle East and Africa Endometriosis Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.3 Global Endometriosis Market Size (2018-2030)
- 4.3.1 Global Endometriosis Revenue Status and Outlook (2018-2030)
- 4.4 Global Endometriosis Market Price Analysis by Regions (2018-2030)
- 5.1 Global Endometriosis Market Revenue and Share by Manufacturers (2018-2022)
- 5.2 Global Endometriosis Industry Mergers and Acquisition Analysis
- 5.3 Global Endometriosis New Launches Analysis
- 5.4 Company Categorization
- 5.5 Global Endometriosis Top Winning Strategies, by Manufacturers (2018-2022)
- 7.1 Endometriosis Industrial Dynamics
- 7.1.1 Global Endometriosis Market Drivers
- 7.1.2 Global Endometriosis Market Restrains
- 7.1.3 Global Endometriosis Market Opportunities
- 7.1.4 Global Endometriosis Market Trends
- 7.2 Endometriosis Market Attractiveness Analysis
- 7.1.1 Market Attractiveness Analysis by Type Segment
- 7.1.2 Market Attractiveness Analysis by Application Segment
- 7.3 PESTEL Analysis for Endometriosis Market
- 7.3.1 Political Factors
- 7.3.2 Economic Factors
- 7.3.3 Social Factors
- 7.3.4 Technological Factors
- 7.3.5 Legal Factors
- 7.3.6 Environmental Factors
- 7.4 Porter’s Five Forces Analysis for Endometriosis Market
- 7.4.1 Bargaining Power of Suppliers
- 7.4.2 Bargaining Power of Buyers
- 7.4.3 Threat of Substitutes
- 7.4.4 Threat of New Entrants
- 7.4.5 Degree of Competition
- 7.5 COVID-19 Impact on Endometriosis Industry
- 7.4.1 Overall Impact of COVID-19 on Endometriosis Industry
- 7.4.2 Post COVID-19 Impact and Recovery Analysis
- 7.4.3 Influencing Factors
- 7.6 Consumer Preference Analysis for Endometriosis Market
- 7.7 Patent Analysis of Endometriosis
- 7.8 Endometriosis Industrial Chain Analysis
- 7.9 Manufacturing Cost Analysis
- 8.1 AbbVie
- 8.1.1 AbbVie Company Basic Information, and Sales Area
- 8.1.2 AbbVie Business Segment/ Overview
- 8.1.3 AbbVie Financials
- 8.1.3.1 Investment in Research and Development
- 8.1.3.2 AbbVie Sales Revenue (2018-2022)
- 8.1.3.3 AbbVie Market Share (2018-2022)
- 8.1.4 AbbVie Recent Developments
- 8.1.5 AbbVie Business Strategy
- 8.1.6 AbbVie Management Change
- 8.1.7 AbbVie SWOT Analysis
- 8.1.7.1 Strength
- 8.1.7.2 Weakness
- 8.1.7.3 Opportunity
- 8.1.7.4 Threats
- 8.1.8 AbbVie COVID-19 Impact Analysis
- 8.2 AstraZeneca
- 8.2.1 AstraZeneca Company Basic Information, and Sales Area
- 8.2.2 AstraZeneca Business Segment/ Overview
- 8.2.3 AstraZeneca Financials
- 8.2.3.1 Investment in Research and Development
- 8.2.3.2 AstraZeneca Sales Revenue (2018-2022)
- 8.2.3.3 AstraZeneca Market Share (2018-2022)
- 8.2.4 AstraZeneca Recent Developments
- 8.2.5 AstraZeneca Business Strategy
- 8.2.6 AstraZeneca Management Change
- 8.2.7 AstraZeneca SWOT Analysis
- 8.2.7.1 Strength
- 8.2.7.2 Weakness
- 8.2.7.3 Opportunity
- 8.2.7.4 Threats
- 8.2.8 AstraZeneca COVID-19 Impact Analysis
- 8.3 Bayer HealthCare
- 8.3.1 Bayer HealthCare Company Basic Information, and Sales Area
- 8.3.2 Bayer HealthCare Business Segment/ Overview
- 8.3.3 Bayer HealthCare Financials
- 8.3.3.1 Investment in Research and Development
- 8.3.3.2 Bayer HealthCare Sales Revenue (2018-2022)
- 8.3.3.3 Bayer HealthCare Market Share (2018-2022)
- 8.3.4 Bayer HealthCare Recent Developments
- 8.3.5 Bayer HealthCare Business Strategy
- 8.3.6 Bayer HealthCare Management Change
- 8.3.7 Bayer HealthCare SWOT Analysis
- 8.3.7.1 Strength
- 8.3.7.2 Weakness
- 8.3.7.3 Opportunity
- 8.3.7.4 Threats
- 8.3.8 Bayer HealthCare COVID-19 Impact Analysis
- 8.4 Pfizer
- 8.4.1 Pfizer Company Basic Information, and Sales Area
- 8.4.2 Pfizer Business Segment/ Overview
- 8.4.3 Pfizer Financials
- 8.4.3.1 Investment in Research and Development
- 8.4.3.2 Pfizer Sales Revenue (2018-2022)
- 8.4.3.3 Pfizer Market Share (2018-2022)
- 8.4.4 Pfizer Recent Developments
- 8.4.5 Pfizer Business Strategy
- 8.4.6 Pfizer Management Change
- 8.4.7 Pfizer SWOT Analysis
- 8.4.7.1 Strength
- 8.4.7.2 Weakness
- 8.4.7.3 Opportunity
- 8.4.7.4 Threats
- 8.4.8 Pfizer COVID-19 Impact Analysis
- 8.5 Addex Therapeutics
- 8.5.1 Addex Therapeutics Company Basic Information, and Sales Area
- 8.5.2 Addex Therapeutics Business Segment/ Overview
- 8.5.3 Addex Therapeutics Financials
- 8.5.3.1 Investment in Research and Development
- 8.5.3.2 Addex Therapeutics Sales Revenue (2018-2022)
- 8.5.3.3 Addex Therapeutics Market Share (2018-2022)
- 8.5.4 Addex Therapeutics Recent Developments
- 8.5.5 Addex Therapeutics Business Strategy
- 8.5.6 Addex Therapeutics Management Change
- 8.5.7 Addex Therapeutics SWOT Analysis
- 8.5.7.1 Strength
- 8.5.7.2 Weakness
- 8.5.7.3 Opportunity
- 8.5.7.4 Threats
- 8.5.8 Addex Therapeutics COVID-19 Impact Analysis
- 8.6 Astellas Pharma
- 8.6.1 Astellas Pharma Company Basic Information, and Sales Area
- 8.6.2 Astellas Pharma Business Segment/ Overview
- 8.6.3 Astellas Pharma Financials
- 8.6.3.1 Investment in Research and Development
- 8.6.3.2 Astellas Pharma Sales Revenue (2018-2022)
- 8.6.3.3 Astellas Pharma Market Share (2018-2022)
- 8.6.4 Astellas Pharma Recent Developments
- 8.6.5 Astellas Pharma Business Strategy
- 8.6.6 Astellas Pharma Management Change
- 8.6.7 Astellas Pharma SWOT Analysis
- 8.6.7.1 Strength
- 8.6.7.2 Weakness
- 8.6.7.3 Opportunity
- 8.6.7.4 Threats
- 8.6.8 Astellas Pharma COVID-19 Impact Analysis
- 8.7 Debiopharm
- 8.7.1 Debiopharm Company Basic Information, and Sales Area
- 8.7.2 Debiopharm Business Segment/ Overview
- 8.7.3 Debiopharm Financials
- 8.7.3.1 Investment in Research and Development
- 8.7.3.2 Debiopharm Sales Revenue (2018-2022)
- 8.7.3.3 Debiopharm Market Share (2018-2022)
- 8.7.4 Debiopharm Recent Developments
- 8.7.5 Debiopharm Business Strategy
- 8.7.6 Debiopharm Management Change
- 8.7.7 Debiopharm SWOT Analysis
- 8.7.7.1 Strength
- 8.7.7.2 Weakness
- 8.7.7.3 Opportunity
- 8.7.7.4 Threats
- 8.7.8 Debiopharm COVID-19 Impact Analysis
- 8.8 ElexoPharm
- 8.8.1 ElexoPharm Company Basic Information, and Sales Area
- 8.8.2 ElexoPharm Business Segment/ Overview
- 8.8.3 ElexoPharm Financials
- 8.8.3.1 Investment in Research and Development
- 8.8.3.2 ElexoPharm Sales Revenue (2018-2022)
- 8.8.3.3 ElexoPharm Market Share (2018-2022)
- 8.8.4 ElexoPharm Recent Developments
- 8.8.5 ElexoPharm Business Strategy
- 8.8.6 ElexoPharm Management Change
- 8.8.7 ElexoPharm SWOT Analysis
- 8.8.7.1 Strength
- 8.8.7.2 Weakness
- 8.8.7.3 Opportunity
- 8.8.7.4 Threats
- 8.8.8 ElexoPharm COVID-19 Impact Analysis
- 8.9 EndoCeutics
- 8.9.1 EndoCeutics Company Basic Information, and Sales Area
- 8.9.2 EndoCeutics Business Segment/ Overview
- 8.9.3 EndoCeutics Financials
- 8.9.3.1 Investment in Research and Development
- 8.9.3.2 EndoCeutics Sales Revenue (2018-2022)
- 8.9.3.3 EndoCeutics Market Share (2018-2022)
- 8.9.4 EndoCeutics Recent Developments
- 8.9.5 EndoCeutics Business Strategy
- 8.9.6 EndoCeutics Management Change
- 8.9.7 EndoCeutics SWOT Analysis
- 8.9.7.1 Strength
- 8.9.7.2 Weakness
- 8.9.7.3 Opportunity
- 8.9.7.4 Threats
- 8.9.8 EndoCeutics COVID-19 Impact Analysis
- 8.10 Euroscreen
- 8.10.1 Euroscreen Company Basic Information, and Sales Area
- 8.10.2 Euroscreen Business Segment/ Overview
- 8.10.3 Euroscreen Financials
- 8.10.3.1 Investment in Research and Development
- 8.10.3.2 Euroscreen Sales Revenue (2018-2022)
- 8.10.3.3 Euroscreen Market Share (2018-2022)
- 8.10.4 Euroscreen Recent Developments
- 8.10.5 Euroscreen Business Strategy
- 8.10.6 Euroscreen Management Change
- 8.10.7 Euroscreen SWOT Analysis
- 8.10.7.1 Strength
- 8.10.7.2 Weakness
- 8.10.7.3 Opportunity
- 8.10.7.4 Threats
- 8.10.8 Euroscreen COVID-19 Impact Analysis
- 8.11 Forendo Pharma
- 8.11.1 Forendo Pharma Company Basic Information, and Sales Area
- 8.11.2 Forendo Pharma Business Segment/ Overview
- 8.11.3 Forendo Pharma Financials
- 8.11.3.1 Investment in Research and Development
- 8.11.3.2 Forendo Pharma Sales Revenue (2018-2022)
- 8.11.3.3 Forendo Pharma Market Share (2018-2022)
- 8.11.4 Forendo Pharma Recent Developments
- 8.11.5 Forendo Pharma Business Strategy
- 8.11.6 Forendo Pharma Management Change
- 8.11.7 Forendo Pharma SWOT Analysis
- 8.11.7.1 Strength
- 8.11.7.2 Weakness
- 8.11.7.3 Opportunity
- 8.11.7.4 Threats
- 8.11.8 Forendo Pharma COVID-19 Impact Analysis
- 8.12 Kissei Pharmaceutical
- 8.12.1 Kissei Pharmaceutical Company Basic Information, and Sales Area
- 8.12.2 Kissei Pharmaceutical Business Segment/ Overview
- 8.12.3 Kissei Pharmaceutical Financials
- 8.12.3.1 Investment in Research and Development
- 8.12.3.2 Kissei Pharmaceutical Sales Revenue (2018-2022)
- 8.12.3.3 Kissei Pharmaceutical Market Share (2018-2022)
- 8.12.4 Kissei Pharmaceutical Recent Developments
- 8.12.5 Kissei Pharmaceutical Business Strategy
- 8.12.6 Kissei Pharmaceutical Management Change
- 8.12.7 Kissei Pharmaceutical SWOT Analysis
- 8.12.7.1 Strength
- 8.12.7.2 Weakness
- 8.12.7.3 Opportunity
- 8.12.7.4 Threats
- 8.12.8 Kissei Pharmaceutical COVID-19 Impact Analysis
- 8.13 Neurocrine Biosciences
- 8.13.1 Neurocrine Biosciences Company Basic Information, and Sales Area
- 8.13.2 Neurocrine Biosciences Business Segment/ Overview
- 8.13.3 Neurocrine Biosciences Financials
- 8.13.3.1 Investment in Research and Development
- 8.13.3.2 Neurocrine Biosciences Sales Revenue (2018-2022)
- 8.13.3.3 Neurocrine Biosciences Market Share (2018-2022)
- 8.13.4 Neurocrine Biosciences Recent Developments
- 8.13.5 Neurocrine Biosciences Business Strategy
- 8.13.6 Neurocrine Biosciences Management Change
- 8.13.7 Neurocrine Biosciences SWOT Analysis
- 8.13.7.1 Strength
- 8.13.7.2 Weakness
- 8.13.7.3 Opportunity
- 8.13.7.4 Threats
- 8.13.8 Neurocrine Biosciences COVID-19 Impact Analysis
- 8.14 Nippon Shinyaku
- 8.14.1 Nippon Shinyaku Company Basic Information, and Sales Area
- 8.14.2 Nippon Shinyaku Business Segment/ Overview
- 8.14.3 Nippon Shinyaku Financials
- 8.14.3.1 Investment in Research and Development
- 8.14.3.2 Nippon Shinyaku Sales Revenue (2018-2022)
- 8.14.3.3 Nippon Shinyaku Market Share (2018-2022)
- 8.14.4 Nippon Shinyaku Recent Developments
- 8.14.5 Nippon Shinyaku Business Strategy
- 8.14.6 Nippon Shinyaku Management Change
- 8.14.7 Nippon Shinyaku SWOT Analysis
- 8.14.7.1 Strength
- 8.14.7.2 Weakness
- 8.14.7.3 Opportunity
- 8.14.7.4 Threats
- 8.14.8 Nippon Shinyaku COVID-19 Impact Analysis
- 8.15 Takeda
- 8.15.1 Takeda Company Basic Information, and Sales Area
- 8.15.2 Takeda Business Segment/ Overview
- 8.15.3 Takeda Financials
- 8.15.3.1 Investment in Research and Development
- 8.15.3.2 Takeda Sales Revenue (2018-2022)
- 8.15.3.3 Takeda Market Share (2018-2022)
- 8.15.4 Takeda Recent Developments
- 8.15.5 Takeda Business Strategy
- 8.15.6 Takeda Management Change
- 8.15.7 Takeda SWOT Analysis
- 8.15.7.1 Strength
- 8.15.7.2 Weakness
- 8.15.7.3 Opportunity
- 8.15.7.4 Threats
- 8.15.8 Takeda COVID-19 Impact Analysis
- 8.16 Bayer AG
- 8.16.1 Bayer AG Company Basic Information, and Sales Area
- 8.16.2 Bayer AG Business Segment/ Overview
- 8.16.3 Bayer AG Financials
- 8.16.3.1 Investment in Research and Development
- 8.16.3.2 Bayer AG Sales Revenue (2018-2022)
- 8.16.3.3 Bayer AG Market Share (2018-2022)
- 8.16.4 Bayer AG Recent Developments
- 8.16.5 Bayer AG Business Strategy
- 8.16.6 Bayer AG Management Change
- 8.16.7 Bayer AG SWOT Analysis
- 8.16.7.1 Strength
- 8.16.7.2 Weakness
- 8.16.7.3 Opportunity
- 8.16.7.4 Threats
- 8.16.8 Bayer AG COVID-19 Impact Analysis
- 8.17 Neurocrine Biosciences
- 8.17.1 Neurocrine Biosciences Company Basic Information, and Sales Area
- 8.17.2 Neurocrine Biosciences Business Segment/ Overview
- 8.17.3 Neurocrine Biosciences Financials
- 8.17.3.1 Investment in Research and Development
- 8.17.3.2 Neurocrine Biosciences Sales Revenue (2018-2022)
- 8.17.3.3 Neurocrine Biosciences Market Share (2018-2022)
- 8.17.4 Neurocrine Biosciences Recent Developments
- 8.17.5 Neurocrine Biosciences Business Strategy
- 8.17.6 Neurocrine Biosciences Management Change
- 8.17.7 Neurocrine Biosciences SWOT Analysis
- 8.17.7.1 Strength
- 8.17.7.2 Weakness
- 8.17.7.3 Opportunity
- 8.17.7.4 Threats
- 8.17.8 Neurocrine Biosciences COVID-19 Impact Analysis
- 9.1 Detailed Qualitative Analysis
- 9.2 Global Endometriosis Revenue and Share (%) by Type (2018-2030)
- 9.2.1 Superficial Peritoneal Lesion Market Size
- 9.2.1.1 Global Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 9.2.1.2 Endometriosis Market for Superficial Peritoneal Lesion, by Country (2021 Vs 2024)
- 9.2.2 Endometrioma Market Size
- 9.2.2.1 Global Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 9.2.2.2 Endometriosis Market for Endometrioma, by Country (2021 Vs 2024)
- 9.2.3 Deeply Infiltrating Endometriosis Market Size
- 9.2.3.1 Global Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 9.2.3.2 Endometriosis Market for Deeply Infiltrating Endometriosis, by Country (2021 Vs 2024)
- 9.2.4 Others Market Size
- 9.2.4.1 Global Others Market Share and Revenue (USD Million) for 2018-2030
- 9.2.4.2 Endometriosis Market for Others, by Country (2021 Vs 2024)
- 9.2.1 Superficial Peritoneal Lesion Market Size
- 10.1 Detailed Qualitative Analysis
- 10.2 Global Endometriosis Revenue and Share (%) by Distribution Channel (2018-2030)
- 10.2.1 Hospital pharmacy Market Size
- 10.2.1.1 Global Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 10.2.1.2 Endometriosis Market for Hospital pharmacy, by Country (2021 Vs 2024)
- 10.2.2 Retail pharmacy Market Size
- 10.2.2.1 Global Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 10.2.2.2 Endometriosis Market for Retail pharmacy, by Country (2021 Vs 2024)
- 10.2.3 Others Market Size
- 10.2.3.1 Global Others Market Share and Revenue (USD Million) for 2018-2030
- 10.2.3.2 Endometriosis Market for Others, by Country (2021 Vs 2024)
- 10.2.1 Hospital pharmacy Market Size
- 11.1 Detailed Qualitative Analysis
- 11.2 Global Endometriosis Revenue and Share (%) by Treatment (2018-2030)
- 11.2.1 NSAIDs Market Size
- 11.2.1.1 Global NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 11.2.1.2 Endometriosis Market for NSAIDs, by Country (2021 Vs 2024)
- 11.2.2 Oral Contraceptive Market Size
- 11.2.2.1 Global Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 11.2.2.2 Endometriosis Market for Oral Contraceptive, by Country (2021 Vs 2024)
- 11.2.3 Gonadotropin Releasing Hormone Market Size
- 11.2.3.1 Global Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 11.2.3.2 Endometriosis Market for Gonadotropin Releasing Hormone, by Country (2021 Vs 2024)
- 11.2.4 Others Market Size
- 11.2.4.1 Global Others Market Share and Revenue (USD Million) for 2018-2030
- 11.2.4.2 Endometriosis Market for Others, by Country (2021 Vs 2024)
- 11.2.1 NSAIDs Market Size
- 12.1 Detailed Qualitative Analysis
- 12.2 Global Endometriosis Market Revenue by Region (2018-2030)
- 12.2 Global Endometriosis Market Share (%) by Region (2018-2030)
- 13.1 North America
- 13.1.1 North America Endometriosis Market Trends and Analysis
- 13.1.2 North America Endometriosis Market by Country, 2018-2030
- 13.1.3 North America Endometriosis Market Attractiveness Analysis by Country
- 13.2 North America Endometriosis Market Size (2018-2030)
- 13.2.1 North America Endometriosis Market (USD Million) by Type (2018-2030)
- 13.2.1.1 Superficial Peritoneal Lesion
- 13.2.1.1.1 North America Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.2 Endometrioma
- 13.2.1.2.1 North America Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.3 Deeply Infiltrating Endometriosis
- 13.2.1.3.1 North America Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.4 Others
- 13.2.1.4.1 North America Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.1 Superficial Peritoneal Lesion
- 13.2.2 North America Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 13.2.2.1 Hospital pharmacy
- 13.2.2.1.1 North America Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.2 Retail pharmacy
- 13.2.2.2.1 North America Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.3 Others
- 13.2.2.3.1 North America Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.1 Hospital pharmacy
- 13.2.3 North America Endometriosis Market (USD Million) by Treatment (2018-2030)
- 13.2.3.1 NSAIDs
- 13.2.3.1.1 North America NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.2 Oral Contraceptive
- 13.2.3.2.1 North America Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.3 Gonadotropin Releasing Hormone
- 13.2.3.3.1 North America Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.4 Others
- 13.2.3.4.1 North America Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.1 NSAIDs
- 13.2.1 North America Endometriosis Market (USD Million) by Type (2018-2030)
- 13.2 United States Endometriosis Market Size (2018-2030)
- 13.2.1 United States Endometriosis Market (USD Million) by Type (2018-2030)
- 13.2.1.1 Superficial Peritoneal Lesion
- 13.2.1.1.1 United States Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.2 Endometrioma
- 13.2.1.2.1 United States Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.3 Deeply Infiltrating Endometriosis
- 13.2.1.3.1 United States Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.4 Others
- 13.2.1.4.1 United States Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.1 Superficial Peritoneal Lesion
- 13.2.2 United States Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 13.2.2.1 Hospital pharmacy
- 13.2.2.1.1 United States Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.2 Retail pharmacy
- 13.2.2.2.1 United States Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.3 Others
- 13.2.2.3.1 United States Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.1 Hospital pharmacy
- 13.2.3 United States Endometriosis Market (USD Million) by Treatment (2018-2030)
- 13.2.3.1 NSAIDs
- 13.2.3.1.1 United States NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.2 Oral Contraceptive
- 13.2.3.2.1 United States Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.3 Gonadotropin Releasing Hormone
- 13.2.3.3.1 United States Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.4 Others
- 13.2.3.4.1 United States Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.1 NSAIDs
- 13.2.1 United States Endometriosis Market (USD Million) by Type (2018-2030)
- 13.2 Canada Endometriosis Market Size (2018-2030)
- 13.2.1 Canada Endometriosis Market (USD Million) by Type (2018-2030)
- 13.2.1.1 Superficial Peritoneal Lesion
- 13.2.1.1.1 Canada Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.2 Endometrioma
- 13.2.1.2.1 Canada Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.3 Deeply Infiltrating Endometriosis
- 13.2.1.3.1 Canada Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.4 Others
- 13.2.1.4.1 Canada Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.1 Superficial Peritoneal Lesion
- 13.2.2 Canada Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 13.2.2.1 Hospital pharmacy
- 13.2.2.1.1 Canada Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.2 Retail pharmacy
- 13.2.2.2.1 Canada Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.3 Others
- 13.2.2.3.1 Canada Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.1 Hospital pharmacy
- 13.2.3 Canada Endometriosis Market (USD Million) by Treatment (2018-2030)
- 13.2.3.1 NSAIDs
- 13.2.3.1.1 Canada NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.2 Oral Contraceptive
- 13.2.3.2.1 Canada Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.3 Gonadotropin Releasing Hormone
- 13.2.3.3.1 Canada Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.4 Others
- 13.2.3.4.1 Canada Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.1 NSAIDs
- 13.2.1 Canada Endometriosis Market (USD Million) by Type (2018-2030)
- 13.2 Mexico Endometriosis Market Size (2018-2030)
- 13.2.1 Mexico Endometriosis Market (USD Million) by Type (2018-2030)
- 13.2.1.1 Superficial Peritoneal Lesion
- 13.2.1.1.1 Mexico Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.2 Endometrioma
- 13.2.1.2.1 Mexico Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.3 Deeply Infiltrating Endometriosis
- 13.2.1.3.1 Mexico Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.4 Others
- 13.2.1.4.1 Mexico Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.1 Superficial Peritoneal Lesion
- 13.2.2 Mexico Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 13.2.2.1 Hospital pharmacy
- 13.2.2.1.1 Mexico Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.2 Retail pharmacy
- 13.2.2.2.1 Mexico Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.3 Others
- 13.2.2.3.1 Mexico Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.1 Hospital pharmacy
- 13.2.3 Mexico Endometriosis Market (USD Million) by Treatment (2018-2030)
- 13.2.3.1 NSAIDs
- 13.2.3.1.1 Mexico NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.2 Oral Contraceptive
- 13.2.3.2.1 Mexico Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.3 Gonadotropin Releasing Hormone
- 13.2.3.3.1 Mexico Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.4 Others
- 13.2.3.4.1 Mexico Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.1 NSAIDs
- 13.2.1 Mexico Endometriosis Market (USD Million) by Type (2018-2030)
- 14.1 Europe
- 14.1.1 Europe Endometriosis Market Trends and Analysis
- 14.1.2 Europe Endometriosis Market by Country, 2018-2030
- 14.1.3 Europe Endometriosis Market Attractiveness Analysis by Country
- 14.2 Europe Endometriosis Market Size (2018-2030)
- 14.2.1 Europe Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.1.1.1 Europe Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Endometrioma
- 14.2.1.2.1 Europe Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Deeply Infiltrating Endometriosis
- 14.2.1.3.1 Europe Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Others
- 14.2.1.4.1 Europe Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.2 Europe Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 14.2.2.1 Hospital pharmacy
- 14.2.2.1.1 Europe Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Retail pharmacy
- 14.2.2.2.1 Europe Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Others
- 14.2.2.3.1 Europe Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Hospital pharmacy
- 14.2.3 Europe Endometriosis Market (USD Million) by Treatment (2018-2030)
- 14.2.3.1 NSAIDs
- 14.2.3.1.1 Europe NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Oral Contraceptive
- 14.2.3.2.1 Europe Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Gonadotropin Releasing Hormone
- 14.2.3.3.1 Europe Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Others
- 14.2.3.4.1 Europe Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 NSAIDs
- 14.2.1 Europe Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2 United Kingdom Endometriosis Market Size (2018-2030)
- 14.2.1 United Kingdom Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.1.1.1 United Kingdom Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Endometrioma
- 14.2.1.2.1 United Kingdom Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Deeply Infiltrating Endometriosis
- 14.2.1.3.1 United Kingdom Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Others
- 14.2.1.4.1 United Kingdom Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.2 United Kingdom Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 14.2.2.1 Hospital pharmacy
- 14.2.2.1.1 United Kingdom Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Retail pharmacy
- 14.2.2.2.1 United Kingdom Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Others
- 14.2.2.3.1 United Kingdom Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Hospital pharmacy
- 14.2.3 United Kingdom Endometriosis Market (USD Million) by Treatment (2018-2030)
- 14.2.3.1 NSAIDs
- 14.2.3.1.1 United Kingdom NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Oral Contraceptive
- 14.2.3.2.1 United Kingdom Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Gonadotropin Releasing Hormone
- 14.2.3.3.1 United Kingdom Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Others
- 14.2.3.4.1 United Kingdom Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 NSAIDs
- 14.2.1 United Kingdom Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2 France Endometriosis Market Size (2018-2030)
- 14.2.1 France Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.1.1.1 France Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Endometrioma
- 14.2.1.2.1 France Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Deeply Infiltrating Endometriosis
- 14.2.1.3.1 France Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Others
- 14.2.1.4.1 France Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.2 France Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 14.2.2.1 Hospital pharmacy
- 14.2.2.1.1 France Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Retail pharmacy
- 14.2.2.2.1 France Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Others
- 14.2.2.3.1 France Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Hospital pharmacy
- 14.2.3 France Endometriosis Market (USD Million) by Treatment (2018-2030)
- 14.2.3.1 NSAIDs
- 14.2.3.1.1 France NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Oral Contraceptive
- 14.2.3.2.1 France Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Gonadotropin Releasing Hormone
- 14.2.3.3.1 France Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Others
- 14.2.3.4.1 France Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 NSAIDs
- 14.2.1 France Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2 Germany Endometriosis Market Size (2018-2030)
- 14.2.1 Germany Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.1.1.1 Germany Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Endometrioma
- 14.2.1.2.1 Germany Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Deeply Infiltrating Endometriosis
- 14.2.1.3.1 Germany Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Others
- 14.2.1.4.1 Germany Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.2 Germany Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 14.2.2.1 Hospital pharmacy
- 14.2.2.1.1 Germany Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Retail pharmacy
- 14.2.2.2.1 Germany Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Others
- 14.2.2.3.1 Germany Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Hospital pharmacy
- 14.2.3 Germany Endometriosis Market (USD Million) by Treatment (2018-2030)
- 14.2.3.1 NSAIDs
- 14.2.3.1.1 Germany NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Oral Contraceptive
- 14.2.3.2.1 Germany Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Gonadotropin Releasing Hormone
- 14.2.3.3.1 Germany Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Others
- 14.2.3.4.1 Germany Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 NSAIDs
- 14.2.1 Germany Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2 Italy Endometriosis Market Size (2018-2030)
- 14.2.1 Italy Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.1.1.1 Italy Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Endometrioma
- 14.2.1.2.1 Italy Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Deeply Infiltrating Endometriosis
- 14.2.1.3.1 Italy Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Others
- 14.2.1.4.1 Italy Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.2 Italy Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 14.2.2.1 Hospital pharmacy
- 14.2.2.1.1 Italy Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Retail pharmacy
- 14.2.2.2.1 Italy Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Others
- 14.2.2.3.1 Italy Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Hospital pharmacy
- 14.2.3 Italy Endometriosis Market (USD Million) by Treatment (2018-2030)
- 14.2.3.1 NSAIDs
- 14.2.3.1.1 Italy NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Oral Contraceptive
- 14.2.3.2.1 Italy Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Gonadotropin Releasing Hormone
- 14.2.3.3.1 Italy Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Others
- 14.2.3.4.1 Italy Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 NSAIDs
- 14.2.1 Italy Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2 Russia Endometriosis Market Size (2018-2030)
- 14.2.1 Russia Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.1.1.1 Russia Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Endometrioma
- 14.2.1.2.1 Russia Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Deeply Infiltrating Endometriosis
- 14.2.1.3.1 Russia Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Others
- 14.2.1.4.1 Russia Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.2 Russia Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 14.2.2.1 Hospital pharmacy
- 14.2.2.1.1 Russia Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Retail pharmacy
- 14.2.2.2.1 Russia Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Others
- 14.2.2.3.1 Russia Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Hospital pharmacy
- 14.2.3 Russia Endometriosis Market (USD Million) by Treatment (2018-2030)
- 14.2.3.1 NSAIDs
- 14.2.3.1.1 Russia NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Oral Contraceptive
- 14.2.3.2.1 Russia Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Gonadotropin Releasing Hormone
- 14.2.3.3.1 Russia Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Others
- 14.2.3.4.1 Russia Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 NSAIDs
- 14.2.1 Russia Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2 Spain Endometriosis Market Size (2018-2030)
- 14.2.1 Spain Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.1.1.1 Spain Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Endometrioma
- 14.2.1.2.1 Spain Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Deeply Infiltrating Endometriosis
- 14.2.1.3.1 Spain Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Others
- 14.2.1.4.1 Spain Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.2 Spain Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 14.2.2.1 Hospital pharmacy
- 14.2.2.1.1 Spain Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Retail pharmacy
- 14.2.2.2.1 Spain Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Others
- 14.2.2.3.1 Spain Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Hospital pharmacy
- 14.2.3 Spain Endometriosis Market (USD Million) by Treatment (2018-2030)
- 14.2.3.1 NSAIDs
- 14.2.3.1.1 Spain NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Oral Contraceptive
- 14.2.3.2.1 Spain Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Gonadotropin Releasing Hormone
- 14.2.3.3.1 Spain Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Others
- 14.2.3.4.1 Spain Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 NSAIDs
- 14.2.1 Spain Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2 Sweden Endometriosis Market Size (2018-2030)
- 14.2.1 Sweden Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.1.1.1 Sweden Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Endometrioma
- 14.2.1.2.1 Sweden Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Deeply Infiltrating Endometriosis
- 14.2.1.3.1 Sweden Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Others
- 14.2.1.4.1 Sweden Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.2 Sweden Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 14.2.2.1 Hospital pharmacy
- 14.2.2.1.1 Sweden Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Retail pharmacy
- 14.2.2.2.1 Sweden Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Others
- 14.2.2.3.1 Sweden Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Hospital pharmacy
- 14.2.3 Sweden Endometriosis Market (USD Million) by Treatment (2018-2030)
- 14.2.3.1 NSAIDs
- 14.2.3.1.1 Sweden NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Oral Contraceptive
- 14.2.3.2.1 Sweden Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Gonadotropin Releasing Hormone
- 14.2.3.3.1 Sweden Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Others
- 14.2.3.4.1 Sweden Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 NSAIDs
- 14.2.1 Sweden Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2 Denmark Endometriosis Market Size (2018-2030)
- 14.2.1 Denmark Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.1.1.1 Denmark Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Endometrioma
- 14.2.1.2.1 Denmark Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Deeply Infiltrating Endometriosis
- 14.2.1.3.1 Denmark Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Others
- 14.2.1.4.1 Denmark Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.2 Denmark Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 14.2.2.1 Hospital pharmacy
- 14.2.2.1.1 Denmark Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Retail pharmacy
- 14.2.2.2.1 Denmark Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Others
- 14.2.2.3.1 Denmark Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Hospital pharmacy
- 14.2.3 Denmark Endometriosis Market (USD Million) by Treatment (2018-2030)
- 14.2.3.1 NSAIDs
- 14.2.3.1.1 Denmark NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Oral Contraceptive
- 14.2.3.2.1 Denmark Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Gonadotropin Releasing Hormone
- 14.2.3.3.1 Denmark Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Others
- 14.2.3.4.1 Denmark Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 NSAIDs
- 14.2.1 Denmark Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2 Netherlands Endometriosis Market Size (2018-2030)
- 14.2.1 Netherlands Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.1.1.1 Netherlands Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Endometrioma
- 14.2.1.2.1 Netherlands Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Deeply Infiltrating Endometriosis
- 14.2.1.3.1 Netherlands Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Others
- 14.2.1.4.1 Netherlands Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.2 Netherlands Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 14.2.2.1 Hospital pharmacy
- 14.2.2.1.1 Netherlands Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Retail pharmacy
- 14.2.2.2.1 Netherlands Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Others
- 14.2.2.3.1 Netherlands Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Hospital pharmacy
- 14.2.3 Netherlands Endometriosis Market (USD Million) by Treatment (2018-2030)
- 14.2.3.1 NSAIDs
- 14.2.3.1.1 Netherlands NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Oral Contraceptive
- 14.2.3.2.1 Netherlands Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Gonadotropin Releasing Hormone
- 14.2.3.3.1 Netherlands Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Others
- 14.2.3.4.1 Netherlands Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 NSAIDs
- 14.2.1 Netherlands Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2 Switzerland Endometriosis Market Size (2018-2030)
- 14.2.1 Switzerland Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.1.1.1 Switzerland Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Endometrioma
- 14.2.1.2.1 Switzerland Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Deeply Infiltrating Endometriosis
- 14.2.1.3.1 Switzerland Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Others
- 14.2.1.4.1 Switzerland Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.2 Switzerland Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 14.2.2.1 Hospital pharmacy
- 14.2.2.1.1 Switzerland Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Retail pharmacy
- 14.2.2.2.1 Switzerland Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Others
- 14.2.2.3.1 Switzerland Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Hospital pharmacy
- 14.2.3 Switzerland Endometriosis Market (USD Million) by Treatment (2018-2030)
- 14.2.3.1 NSAIDs
- 14.2.3.1.1 Switzerland NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Oral Contraceptive
- 14.2.3.2.1 Switzerland Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Gonadotropin Releasing Hormone
- 14.2.3.3.1 Switzerland Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Others
- 14.2.3.4.1 Switzerland Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 NSAIDs
- 14.2.1 Switzerland Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2 Belgium Endometriosis Market Size (2018-2030)
- 14.2.1 Belgium Endometriosis Market (USD Million) by Type (2018-2030)
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.1.1.1 Belgium Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Endometrioma
- 14.2.1.2.1 Belgium Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Deeply Infiltrating Endometriosis
- 14.2.1.3.1 Belgium Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Others
- 14.2.1.4.1 Belgium Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Superficial Peritoneal Lesion
- 14.2.2 Belgium Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 14.2.2.1 Hospital pharmacy
- 14.2.2.1.1 Belgium Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Retail pharmacy
- 14.2.2.2.1 Belgium Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.3 Others
- 14.2.2.3.1 Belgium Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Hospital pharmacy
- 14.2.3 Belgium Endometriosis Market (USD Million) by Treatment (2018-2030)
- 14.2.3.1 NSAIDs
- 14.2.3.1.1 Belgium NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Oral Contraceptive
- 14.2.3.2.1 Belgium Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.3 Gonadotropin Releasing Hormone
- 14.2.3.3.1 Belgium Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.4 Others
- 14.2.3.4.1 Belgium Others Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.1 NSAIDs
- 14.2.1 Belgium Endometriosis Market (USD Million) by Type (2018-2030)
- 15.1 Asia Pacific
- 15.1.1 Asia Pacific Endometriosis Market Trends and Analysis
- 15.1.2 Asia Pacific Endometriosis Market by Country, 2018-2030
- 15.1.3 Asia Pacific Endometriosis Market Attractiveness Analysis by Country
- 15.2 Asia Pacific Endometriosis Market Size (2018-2030)
- 15.2.1 Asia Pacific Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.1.1.1 Asia Pacific Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Endometrioma
- 15.2.1.2.1 Asia Pacific Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Deeply Infiltrating Endometriosis
- 15.2.1.3.1 Asia Pacific Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Others
- 15.2.1.4.1 Asia Pacific Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.2 Asia Pacific Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 15.2.2.1 Hospital pharmacy
- 15.2.2.1.1 Asia Pacific Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Retail pharmacy
- 15.2.2.2.1 Asia Pacific Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Others
- 15.2.2.3.1 Asia Pacific Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Hospital pharmacy
- 15.2.3 Asia Pacific Endometriosis Market (USD Million) by Treatment (2018-2030)
- 15.2.3.1 NSAIDs
- 15.2.3.1.1 Asia Pacific NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Oral Contraceptive
- 15.2.3.2.1 Asia Pacific Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Gonadotropin Releasing Hormone
- 15.2.3.3.1 Asia Pacific Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Others
- 15.2.3.4.1 Asia Pacific Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 NSAIDs
- 15.2.1 Asia Pacific Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2 China Endometriosis Market Size (2018-2030)
- 15.2.1 China Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.1.1.1 China Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Endometrioma
- 15.2.1.2.1 China Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Deeply Infiltrating Endometriosis
- 15.2.1.3.1 China Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Others
- 15.2.1.4.1 China Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.2 China Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 15.2.2.1 Hospital pharmacy
- 15.2.2.1.1 China Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Retail pharmacy
- 15.2.2.2.1 China Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Others
- 15.2.2.3.1 China Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Hospital pharmacy
- 15.2.3 China Endometriosis Market (USD Million) by Treatment (2018-2030)
- 15.2.3.1 NSAIDs
- 15.2.3.1.1 China NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Oral Contraceptive
- 15.2.3.2.1 China Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Gonadotropin Releasing Hormone
- 15.2.3.3.1 China Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Others
- 15.2.3.4.1 China Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 NSAIDs
- 15.2.1 China Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2 Japan Endometriosis Market Size (2018-2030)
- 15.2.1 Japan Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.1.1.1 Japan Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Endometrioma
- 15.2.1.2.1 Japan Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Deeply Infiltrating Endometriosis
- 15.2.1.3.1 Japan Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Others
- 15.2.1.4.1 Japan Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.2 Japan Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 15.2.2.1 Hospital pharmacy
- 15.2.2.1.1 Japan Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Retail pharmacy
- 15.2.2.2.1 Japan Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Others
- 15.2.2.3.1 Japan Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Hospital pharmacy
- 15.2.3 Japan Endometriosis Market (USD Million) by Treatment (2018-2030)
- 15.2.3.1 NSAIDs
- 15.2.3.1.1 Japan NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Oral Contraceptive
- 15.2.3.2.1 Japan Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Gonadotropin Releasing Hormone
- 15.2.3.3.1 Japan Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Others
- 15.2.3.4.1 Japan Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 NSAIDs
- 15.2.1 Japan Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2 Korea Endometriosis Market Size (2018-2030)
- 15.2.1 Korea Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.1.1.1 Korea Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Endometrioma
- 15.2.1.2.1 Korea Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Deeply Infiltrating Endometriosis
- 15.2.1.3.1 Korea Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Others
- 15.2.1.4.1 Korea Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.2 Korea Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 15.2.2.1 Hospital pharmacy
- 15.2.2.1.1 Korea Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Retail pharmacy
- 15.2.2.2.1 Korea Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Others
- 15.2.2.3.1 Korea Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Hospital pharmacy
- 15.2.3 Korea Endometriosis Market (USD Million) by Treatment (2018-2030)
- 15.2.3.1 NSAIDs
- 15.2.3.1.1 Korea NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Oral Contraceptive
- 15.2.3.2.1 Korea Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Gonadotropin Releasing Hormone
- 15.2.3.3.1 Korea Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Others
- 15.2.3.4.1 Korea Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 NSAIDs
- 15.2.1 Korea Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2 India Endometriosis Market Size (2018-2030)
- 15.2.1 India Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.1.1.1 India Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Endometrioma
- 15.2.1.2.1 India Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Deeply Infiltrating Endometriosis
- 15.2.1.3.1 India Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Others
- 15.2.1.4.1 India Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.2 India Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 15.2.2.1 Hospital pharmacy
- 15.2.2.1.1 India Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Retail pharmacy
- 15.2.2.2.1 India Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Others
- 15.2.2.3.1 India Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Hospital pharmacy
- 15.2.3 India Endometriosis Market (USD Million) by Treatment (2018-2030)
- 15.2.3.1 NSAIDs
- 15.2.3.1.1 India NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Oral Contraceptive
- 15.2.3.2.1 India Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Gonadotropin Releasing Hormone
- 15.2.3.3.1 India Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Others
- 15.2.3.4.1 India Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 NSAIDs
- 15.2.1 India Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2 Australia Endometriosis Market Size (2018-2030)
- 15.2.1 Australia Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.1.1.1 Australia Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Endometrioma
- 15.2.1.2.1 Australia Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Deeply Infiltrating Endometriosis
- 15.2.1.3.1 Australia Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Others
- 15.2.1.4.1 Australia Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.2 Australia Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 15.2.2.1 Hospital pharmacy
- 15.2.2.1.1 Australia Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Retail pharmacy
- 15.2.2.2.1 Australia Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Others
- 15.2.2.3.1 Australia Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Hospital pharmacy
- 15.2.3 Australia Endometriosis Market (USD Million) by Treatment (2018-2030)
- 15.2.3.1 NSAIDs
- 15.2.3.1.1 Australia NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Oral Contraceptive
- 15.2.3.2.1 Australia Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Gonadotropin Releasing Hormone
- 15.2.3.3.1 Australia Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Others
- 15.2.3.4.1 Australia Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 NSAIDs
- 15.2.1 Australia Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2 Philippines Endometriosis Market Size (2018-2030)
- 15.2.1 Philippines Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.1.1.1 Philippines Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Endometrioma
- 15.2.1.2.1 Philippines Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Deeply Infiltrating Endometriosis
- 15.2.1.3.1 Philippines Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Others
- 15.2.1.4.1 Philippines Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.2 Philippines Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 15.2.2.1 Hospital pharmacy
- 15.2.2.1.1 Philippines Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Retail pharmacy
- 15.2.2.2.1 Philippines Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Others
- 15.2.2.3.1 Philippines Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Hospital pharmacy
- 15.2.3 Philippines Endometriosis Market (USD Million) by Treatment (2018-2030)
- 15.2.3.1 NSAIDs
- 15.2.3.1.1 Philippines NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Oral Contraceptive
- 15.2.3.2.1 Philippines Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Gonadotropin Releasing Hormone
- 15.2.3.3.1 Philippines Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Others
- 15.2.3.4.1 Philippines Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 NSAIDs
- 15.2.1 Philippines Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2 Singapore Endometriosis Market Size (2018-2030)
- 15.2.1 Singapore Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.1.1.1 Singapore Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Endometrioma
- 15.2.1.2.1 Singapore Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Deeply Infiltrating Endometriosis
- 15.2.1.3.1 Singapore Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Others
- 15.2.1.4.1 Singapore Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.2 Singapore Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 15.2.2.1 Hospital pharmacy
- 15.2.2.1.1 Singapore Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Retail pharmacy
- 15.2.2.2.1 Singapore Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Others
- 15.2.2.3.1 Singapore Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Hospital pharmacy
- 15.2.3 Singapore Endometriosis Market (USD Million) by Treatment (2018-2030)
- 15.2.3.1 NSAIDs
- 15.2.3.1.1 Singapore NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Oral Contraceptive
- 15.2.3.2.1 Singapore Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Gonadotropin Releasing Hormone
- 15.2.3.3.1 Singapore Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Others
- 15.2.3.4.1 Singapore Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 NSAIDs
- 15.2.1 Singapore Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2 Malaysia Endometriosis Market Size (2018-2030)
- 15.2.1 Malaysia Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.1.1.1 Malaysia Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Endometrioma
- 15.2.1.2.1 Malaysia Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Deeply Infiltrating Endometriosis
- 15.2.1.3.1 Malaysia Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Others
- 15.2.1.4.1 Malaysia Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.2 Malaysia Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 15.2.2.1 Hospital pharmacy
- 15.2.2.1.1 Malaysia Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Retail pharmacy
- 15.2.2.2.1 Malaysia Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Others
- 15.2.2.3.1 Malaysia Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Hospital pharmacy
- 15.2.3 Malaysia Endometriosis Market (USD Million) by Treatment (2018-2030)
- 15.2.3.1 NSAIDs
- 15.2.3.1.1 Malaysia NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Oral Contraceptive
- 15.2.3.2.1 Malaysia Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Gonadotropin Releasing Hormone
- 15.2.3.3.1 Malaysia Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Others
- 15.2.3.4.1 Malaysia Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 NSAIDs
- 15.2.1 Malaysia Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2 Thailand Endometriosis Market Size (2018-2030)
- 15.2.1 Thailand Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.1.1.1 Thailand Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Endometrioma
- 15.2.1.2.1 Thailand Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Deeply Infiltrating Endometriosis
- 15.2.1.3.1 Thailand Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Others
- 15.2.1.4.1 Thailand Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.2 Thailand Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 15.2.2.1 Hospital pharmacy
- 15.2.2.1.1 Thailand Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Retail pharmacy
- 15.2.2.2.1 Thailand Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Others
- 15.2.2.3.1 Thailand Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Hospital pharmacy
- 15.2.3 Thailand Endometriosis Market (USD Million) by Treatment (2018-2030)
- 15.2.3.1 NSAIDs
- 15.2.3.1.1 Thailand NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Oral Contraceptive
- 15.2.3.2.1 Thailand Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Gonadotropin Releasing Hormone
- 15.2.3.3.1 Thailand Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Others
- 15.2.3.4.1 Thailand Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 NSAIDs
- 15.2.1 Thailand Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2 Indonesia Endometriosis Market Size (2018-2030)
- 15.2.1 Indonesia Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.1.1.1 Indonesia Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Endometrioma
- 15.2.1.2.1 Indonesia Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Deeply Infiltrating Endometriosis
- 15.2.1.3.1 Indonesia Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Others
- 15.2.1.4.1 Indonesia Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.2 Indonesia Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 15.2.2.1 Hospital pharmacy
- 15.2.2.1.1 Indonesia Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Retail pharmacy
- 15.2.2.2.1 Indonesia Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Others
- 15.2.2.3.1 Indonesia Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Hospital pharmacy
- 15.2.3 Indonesia Endometriosis Market (USD Million) by Treatment (2018-2030)
- 15.2.3.1 NSAIDs
- 15.2.3.1.1 Indonesia NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Oral Contraceptive
- 15.2.3.2.1 Indonesia Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Gonadotropin Releasing Hormone
- 15.2.3.3.1 Indonesia Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Others
- 15.2.3.4.1 Indonesia Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 NSAIDs
- 15.2.1 Indonesia Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2 Rest of APAC Endometriosis Market Size (2018-2030)
- 15.2.1 Rest of APAC Endometriosis Market (USD Million) by Type (2018-2030)
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.1.1.1 Rest of APAC Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Endometrioma
- 15.2.1.2.1 Rest of APAC Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Deeply Infiltrating Endometriosis
- 15.2.1.3.1 Rest of APAC Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Others
- 15.2.1.4.1 Rest of APAC Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Superficial Peritoneal Lesion
- 15.2.2 Rest of APAC Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 15.2.2.1 Hospital pharmacy
- 15.2.2.1.1 Rest of APAC Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Retail pharmacy
- 15.2.2.2.1 Rest of APAC Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.3 Others
- 15.2.2.3.1 Rest of APAC Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Hospital pharmacy
- 15.2.3 Rest of APAC Endometriosis Market (USD Million) by Treatment (2018-2030)
- 15.2.3.1 NSAIDs
- 15.2.3.1.1 Rest of APAC NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.2 Oral Contraceptive
- 15.2.3.2.1 Rest of APAC Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.3 Gonadotropin Releasing Hormone
- 15.2.3.3.1 Rest of APAC Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.4 Others
- 15.2.3.4.1 Rest of APAC Others Market Share and Revenue (USD Million) for 2018-2030
- 15.2.3.1 NSAIDs
- 15.2.1 Rest of APAC Endometriosis Market (USD Million) by Type (2018-2030)
- 16.1 Latin America
- 16.1.1 Latin America Endometriosis Market Trends and Analysis
- 16.1.2 Latin America Endometriosis Market by Country, 2018-2030
- 16.1.3 Latin America Endometriosis Market Attractiveness Analysis by Country
- 16.2 Latin America Endometriosis Market Size (2018-2030)
- 16.2.1 Latin America Endometriosis Market (USD Million) by Type (2018-2030)
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.1.1.1 Latin America Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.2 Endometrioma
- 16.2.1.2.1 Latin America Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.3 Deeply Infiltrating Endometriosis
- 16.2.1.3.1 Latin America Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.4 Others
- 16.2.1.4.1 Latin America Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.2 Latin America Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 16.2.2.1 Hospital pharmacy
- 16.2.2.1.1 Latin America Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.2 Retail pharmacy
- 16.2.2.2.1 Latin America Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.3 Others
- 16.2.2.3.1 Latin America Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.1 Hospital pharmacy
- 16.2.3 Latin America Endometriosis Market (USD Million) by Treatment (2018-2030)
- 16.2.3.1 NSAIDs
- 16.2.3.1.1 Latin America NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.2 Oral Contraceptive
- 16.2.3.2.1 Latin America Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.3 Gonadotropin Releasing Hormone
- 16.2.3.3.1 Latin America Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.4 Others
- 16.2.3.4.1 Latin America Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.1 NSAIDs
- 16.2.1 Latin America Endometriosis Market (USD Million) by Type (2018-2030)
- 16.2 Brazil Endometriosis Market Size (2018-2030)
- 16.2.1 Brazil Endometriosis Market (USD Million) by Type (2018-2030)
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.1.1.1 Brazil Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.2 Endometrioma
- 16.2.1.2.1 Brazil Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.3 Deeply Infiltrating Endometriosis
- 16.2.1.3.1 Brazil Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.4 Others
- 16.2.1.4.1 Brazil Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.2 Brazil Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 16.2.2.1 Hospital pharmacy
- 16.2.2.1.1 Brazil Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.2 Retail pharmacy
- 16.2.2.2.1 Brazil Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.3 Others
- 16.2.2.3.1 Brazil Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.1 Hospital pharmacy
- 16.2.3 Brazil Endometriosis Market (USD Million) by Treatment (2018-2030)
- 16.2.3.1 NSAIDs
- 16.2.3.1.1 Brazil NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.2 Oral Contraceptive
- 16.2.3.2.1 Brazil Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.3 Gonadotropin Releasing Hormone
- 16.2.3.3.1 Brazil Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.4 Others
- 16.2.3.4.1 Brazil Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.1 NSAIDs
- 16.2.1 Brazil Endometriosis Market (USD Million) by Type (2018-2030)
- 16.2 Argentina Endometriosis Market Size (2018-2030)
- 16.2.1 Argentina Endometriosis Market (USD Million) by Type (2018-2030)
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.1.1.1 Argentina Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.2 Endometrioma
- 16.2.1.2.1 Argentina Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.3 Deeply Infiltrating Endometriosis
- 16.2.1.3.1 Argentina Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.4 Others
- 16.2.1.4.1 Argentina Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.2 Argentina Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 16.2.2.1 Hospital pharmacy
- 16.2.2.1.1 Argentina Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.2 Retail pharmacy
- 16.2.2.2.1 Argentina Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.3 Others
- 16.2.2.3.1 Argentina Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.1 Hospital pharmacy
- 16.2.3 Argentina Endometriosis Market (USD Million) by Treatment (2018-2030)
- 16.2.3.1 NSAIDs
- 16.2.3.1.1 Argentina NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.2 Oral Contraceptive
- 16.2.3.2.1 Argentina Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.3 Gonadotropin Releasing Hormone
- 16.2.3.3.1 Argentina Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.4 Others
- 16.2.3.4.1 Argentina Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.1 NSAIDs
- 16.2.1 Argentina Endometriosis Market (USD Million) by Type (2018-2030)
- 16.2 Colombia Endometriosis Market Size (2018-2030)
- 16.2.1 Colombia Endometriosis Market (USD Million) by Type (2018-2030)
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.1.1.1 Colombia Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.2 Endometrioma
- 16.2.1.2.1 Colombia Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.3 Deeply Infiltrating Endometriosis
- 16.2.1.3.1 Colombia Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.4 Others
- 16.2.1.4.1 Colombia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.2 Colombia Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 16.2.2.1 Hospital pharmacy
- 16.2.2.1.1 Colombia Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.2 Retail pharmacy
- 16.2.2.2.1 Colombia Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.3 Others
- 16.2.2.3.1 Colombia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.1 Hospital pharmacy
- 16.2.3 Colombia Endometriosis Market (USD Million) by Treatment (2018-2030)
- 16.2.3.1 NSAIDs
- 16.2.3.1.1 Colombia NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.2 Oral Contraceptive
- 16.2.3.2.1 Colombia Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.3 Gonadotropin Releasing Hormone
- 16.2.3.3.1 Colombia Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.4 Others
- 16.2.3.4.1 Colombia Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.1 NSAIDs
- 16.2.1 Colombia Endometriosis Market (USD Million) by Type (2018-2030)
- 16.2 Peru Endometriosis Market Size (2018-2030)
- 16.2.1 Peru Endometriosis Market (USD Million) by Type (2018-2030)
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.1.1.1 Peru Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.2 Endometrioma
- 16.2.1.2.1 Peru Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.3 Deeply Infiltrating Endometriosis
- 16.2.1.3.1 Peru Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.4 Others
- 16.2.1.4.1 Peru Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.2 Peru Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 16.2.2.1 Hospital pharmacy
- 16.2.2.1.1 Peru Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.2 Retail pharmacy
- 16.2.2.2.1 Peru Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.3 Others
- 16.2.2.3.1 Peru Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.1 Hospital pharmacy
- 16.2.3 Peru Endometriosis Market (USD Million) by Treatment (2018-2030)
- 16.2.3.1 NSAIDs
- 16.2.3.1.1 Peru NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.2 Oral Contraceptive
- 16.2.3.2.1 Peru Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.3 Gonadotropin Releasing Hormone
- 16.2.3.3.1 Peru Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.4 Others
- 16.2.3.4.1 Peru Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.1 NSAIDs
- 16.2.1 Peru Endometriosis Market (USD Million) by Type (2018-2030)
- 16.2 Chile Endometriosis Market Size (2018-2030)
- 16.2.1 Chile Endometriosis Market (USD Million) by Type (2018-2030)
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.1.1.1 Chile Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.2 Endometrioma
- 16.2.1.2.1 Chile Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.3 Deeply Infiltrating Endometriosis
- 16.2.1.3.1 Chile Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.4 Others
- 16.2.1.4.1 Chile Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.2 Chile Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 16.2.2.1 Hospital pharmacy
- 16.2.2.1.1 Chile Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.2 Retail pharmacy
- 16.2.2.2.1 Chile Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.3 Others
- 16.2.2.3.1 Chile Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.1 Hospital pharmacy
- 16.2.3 Chile Endometriosis Market (USD Million) by Treatment (2018-2030)
- 16.2.3.1 NSAIDs
- 16.2.3.1.1 Chile NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.2 Oral Contraceptive
- 16.2.3.2.1 Chile Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.3 Gonadotropin Releasing Hormone
- 16.2.3.3.1 Chile Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.4 Others
- 16.2.3.4.1 Chile Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.1 NSAIDs
- 16.2.1 Chile Endometriosis Market (USD Million) by Type (2018-2030)
- 16.2 Rest of South America Endometriosis Market Size (2018-2030)
- 16.2.1 Rest of South America Endometriosis Market (USD Million) by Type (2018-2030)
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.1.1.1 Rest of South America Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.2 Endometrioma
- 16.2.1.2.1 Rest of South America Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.3 Deeply Infiltrating Endometriosis
- 16.2.1.3.1 Rest of South America Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.4 Others
- 16.2.1.4.1 Rest of South America Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.1 Superficial Peritoneal Lesion
- 16.2.2 Rest of South America Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 16.2.2.1 Hospital pharmacy
- 16.2.2.1.1 Rest of South America Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.2 Retail pharmacy
- 16.2.2.2.1 Rest of South America Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.3 Others
- 16.2.2.3.1 Rest of South America Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.1 Hospital pharmacy
- 16.2.3 Rest of South America Endometriosis Market (USD Million) by Treatment (2018-2030)
- 16.2.3.1 NSAIDs
- 16.2.3.1.1 Rest of South America NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.2 Oral Contraceptive
- 16.2.3.2.1 Rest of South America Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.3 Gonadotropin Releasing Hormone
- 16.2.3.3.1 Rest of South America Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.4 Others
- 16.2.3.4.1 Rest of South America Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.1 NSAIDs
- 16.2.1 Rest of South America Endometriosis Market (USD Million) by Type (2018-2030)
- 17.1 Middle East and Africa
- 17.1.1 Middle East and Africa Endometriosis Market Trends and Analysis
- 17.1.2 Middle East and Africa Endometriosis Market by Country, 2018-2030
- 17.1.3 Middle East and Africa Endometriosis Market Attractiveness Analysis by Country
- 17.2 Middle East and Africa Endometriosis Market Size (2018-2030)
- 17.2.1 Middle East and Africa Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.1.1.1 Middle East and Africa Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Endometrioma
- 17.2.1.2.1 Middle East and Africa Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.3 Deeply Infiltrating Endometriosis
- 17.2.1.3.1 Middle East and Africa Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.4 Others
- 17.2.1.4.1 Middle East and Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.2 Middle East and Africa Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 17.2.2.1 Hospital pharmacy
- 17.2.2.1.1 Middle East and Africa Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Retail pharmacy
- 17.2.2.2.1 Middle East and Africa Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.3 Others
- 17.2.2.3.1 Middle East and Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Hospital pharmacy
- 17.2.3 Middle East and Africa Endometriosis Market (USD Million) by Treatment (2018-2030)
- 17.2.3.1 NSAIDs
- 17.2.3.1.1 Middle East and Africa NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Oral Contraceptive
- 17.2.3.2.1 Middle East and Africa Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.3 Gonadotropin Releasing Hormone
- 17.2.3.3.1 Middle East and Africa Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.4 Others
- 17.2.3.4.1 Middle East and Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 NSAIDs
- 17.2.1 Middle East and Africa Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2 Saudi Arabia Endometriosis Market Size (2018-2030)
- 17.2.1 Saudi Arabia Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.1.1.1 Saudi Arabia Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Endometrioma
- 17.2.1.2.1 Saudi Arabia Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.3 Deeply Infiltrating Endometriosis
- 17.2.1.3.1 Saudi Arabia Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.4 Others
- 17.2.1.4.1 Saudi Arabia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.2 Saudi Arabia Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 17.2.2.1 Hospital pharmacy
- 17.2.2.1.1 Saudi Arabia Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Retail pharmacy
- 17.2.2.2.1 Saudi Arabia Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.3 Others
- 17.2.2.3.1 Saudi Arabia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Hospital pharmacy
- 17.2.3 Saudi Arabia Endometriosis Market (USD Million) by Treatment (2018-2030)
- 17.2.3.1 NSAIDs
- 17.2.3.1.1 Saudi Arabia NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Oral Contraceptive
- 17.2.3.2.1 Saudi Arabia Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.3 Gonadotropin Releasing Hormone
- 17.2.3.3.1 Saudi Arabia Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.4 Others
- 17.2.3.4.1 Saudi Arabia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 NSAIDs
- 17.2.1 Saudi Arabia Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2 Turkey Endometriosis Market Size (2018-2030)
- 17.2.1 Turkey Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.1.1.1 Turkey Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Endometrioma
- 17.2.1.2.1 Turkey Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.3 Deeply Infiltrating Endometriosis
- 17.2.1.3.1 Turkey Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.4 Others
- 17.2.1.4.1 Turkey Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.2 Turkey Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 17.2.2.1 Hospital pharmacy
- 17.2.2.1.1 Turkey Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Retail pharmacy
- 17.2.2.2.1 Turkey Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.3 Others
- 17.2.2.3.1 Turkey Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Hospital pharmacy
- 17.2.3 Turkey Endometriosis Market (USD Million) by Treatment (2018-2030)
- 17.2.3.1 NSAIDs
- 17.2.3.1.1 Turkey NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Oral Contraceptive
- 17.2.3.2.1 Turkey Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.3 Gonadotropin Releasing Hormone
- 17.2.3.3.1 Turkey Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.4 Others
- 17.2.3.4.1 Turkey Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 NSAIDs
- 17.2.1 Turkey Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2 Nigeria Endometriosis Market Size (2018-2030)
- 17.2.1 Nigeria Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.1.1.1 Nigeria Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Endometrioma
- 17.2.1.2.1 Nigeria Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.3 Deeply Infiltrating Endometriosis
- 17.2.1.3.1 Nigeria Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.4 Others
- 17.2.1.4.1 Nigeria Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.2 Nigeria Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 17.2.2.1 Hospital pharmacy
- 17.2.2.1.1 Nigeria Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Retail pharmacy
- 17.2.2.2.1 Nigeria Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.3 Others
- 17.2.2.3.1 Nigeria Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Hospital pharmacy
- 17.2.3 Nigeria Endometriosis Market (USD Million) by Treatment (2018-2030)
- 17.2.3.1 NSAIDs
- 17.2.3.1.1 Nigeria NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Oral Contraceptive
- 17.2.3.2.1 Nigeria Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.3 Gonadotropin Releasing Hormone
- 17.2.3.3.1 Nigeria Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.4 Others
- 17.2.3.4.1 Nigeria Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 NSAIDs
- 17.2.1 Nigeria Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2 UAE Endometriosis Market Size (2018-2030)
- 17.2.1 UAE Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.1.1.1 UAE Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Endometrioma
- 17.2.1.2.1 UAE Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.3 Deeply Infiltrating Endometriosis
- 17.2.1.3.1 UAE Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.4 Others
- 17.2.1.4.1 UAE Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.2 UAE Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 17.2.2.1 Hospital pharmacy
- 17.2.2.1.1 UAE Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Retail pharmacy
- 17.2.2.2.1 UAE Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.3 Others
- 17.2.2.3.1 UAE Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Hospital pharmacy
- 17.2.3 UAE Endometriosis Market (USD Million) by Treatment (2018-2030)
- 17.2.3.1 NSAIDs
- 17.2.3.1.1 UAE NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Oral Contraceptive
- 17.2.3.2.1 UAE Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.3 Gonadotropin Releasing Hormone
- 17.2.3.3.1 UAE Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.4 Others
- 17.2.3.4.1 UAE Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 NSAIDs
- 17.2.1 UAE Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2 Egypt Endometriosis Market Size (2018-2030)
- 17.2.1 Egypt Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.1.1.1 Egypt Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Endometrioma
- 17.2.1.2.1 Egypt Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.3 Deeply Infiltrating Endometriosis
- 17.2.1.3.1 Egypt Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.4 Others
- 17.2.1.4.1 Egypt Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.2 Egypt Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 17.2.2.1 Hospital pharmacy
- 17.2.2.1.1 Egypt Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Retail pharmacy
- 17.2.2.2.1 Egypt Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.3 Others
- 17.2.2.3.1 Egypt Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Hospital pharmacy
- 17.2.3 Egypt Endometriosis Market (USD Million) by Treatment (2018-2030)
- 17.2.3.1 NSAIDs
- 17.2.3.1.1 Egypt NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Oral Contraceptive
- 17.2.3.2.1 Egypt Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.3 Gonadotropin Releasing Hormone
- 17.2.3.3.1 Egypt Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.4 Others
- 17.2.3.4.1 Egypt Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 NSAIDs
- 17.2.1 Egypt Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2 South Africa Endometriosis Market Size (2018-2030)
- 17.2.1 South Africa Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.1.1.1 South Africa Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Endometrioma
- 17.2.1.2.1 South Africa Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.3 Deeply Infiltrating Endometriosis
- 17.2.1.3.1 South Africa Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.4 Others
- 17.2.1.4.1 South Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.2 South Africa Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 17.2.2.1 Hospital pharmacy
- 17.2.2.1.1 South Africa Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Retail pharmacy
- 17.2.2.2.1 South Africa Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.3 Others
- 17.2.2.3.1 South Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Hospital pharmacy
- 17.2.3 South Africa Endometriosis Market (USD Million) by Treatment (2018-2030)
- 17.2.3.1 NSAIDs
- 17.2.3.1.1 South Africa NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Oral Contraceptive
- 17.2.3.2.1 South Africa Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.3 Gonadotropin Releasing Hormone
- 17.2.3.3.1 South Africa Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.4 Others
- 17.2.3.4.1 South Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 NSAIDs
- 17.2.1 South Africa Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2 GCC Countries Endometriosis Market Size (2018-2030)
- 17.2.1 GCC Countries Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.1.1.1 GCC Countries Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Endometrioma
- 17.2.1.2.1 GCC Countries Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.3 Deeply Infiltrating Endometriosis
- 17.2.1.3.1 GCC Countries Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.4 Others
- 17.2.1.4.1 GCC Countries Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.2 GCC Countries Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 17.2.2.1 Hospital pharmacy
- 17.2.2.1.1 GCC Countries Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Retail pharmacy
- 17.2.2.2.1 GCC Countries Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.3 Others
- 17.2.2.3.1 GCC Countries Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Hospital pharmacy
- 17.2.3 GCC Countries Endometriosis Market (USD Million) by Treatment (2018-2030)
- 17.2.3.1 NSAIDs
- 17.2.3.1.1 GCC Countries NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Oral Contraceptive
- 17.2.3.2.1 GCC Countries Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.3 Gonadotropin Releasing Hormone
- 17.2.3.3.1 GCC Countries Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.4 Others
- 17.2.3.4.1 GCC Countries Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 NSAIDs
- 17.2.1 GCC Countries Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2 Rest of MEA Endometriosis Market Size (2018-2030)
- 17.2.1 Rest of MEA Endometriosis Market (USD Million) by Type (2018-2030)
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.1.1.1 Rest of MEA Superficial Peritoneal Lesion Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Endometrioma
- 17.2.1.2.1 Rest of MEA Endometrioma Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.3 Deeply Infiltrating Endometriosis
- 17.2.1.3.1 Rest of MEA Deeply Infiltrating Endometriosis Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.4 Others
- 17.2.1.4.1 Rest of MEA Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Superficial Peritoneal Lesion
- 17.2.2 Rest of MEA Endometriosis Market (USD Million) by Distribution Channel (2018-2030)
- 17.2.2.1 Hospital pharmacy
- 17.2.2.1.1 Rest of MEA Hospital pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Retail pharmacy
- 17.2.2.2.1 Rest of MEA Retail pharmacy Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.3 Others
- 17.2.2.3.1 Rest of MEA Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Hospital pharmacy
- 17.2.3 Rest of MEA Endometriosis Market (USD Million) by Treatment (2018-2030)
- 17.2.3.1 NSAIDs
- 17.2.3.1.1 Rest of MEA NSAIDs Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Oral Contraceptive
- 17.2.3.2.1 Rest of MEA Oral Contraceptive Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.3 Gonadotropin Releasing Hormone
- 17.2.3.3.1 Rest of MEA Gonadotropin Releasing Hormone Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.4 Others
- 17.2.3.4.1 Rest of MEA Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 NSAIDs
- 17.2.1 Rest of MEA Endometriosis Market (USD Million) by Type (2018-2030)
- 18.1 Key Takeaways
- 18.2 Analyst Point of View
Segmentation Level Customization | |
Global level Data Customization | |
Region level Data Customization | |
Country level Data Customization | |
Company Level | |
Additional Data Analysis | |
Additional Qualitative Data | |
Additional Quantitative Data | |
Service Level Customization | Report Format Alteration |
We have various report editions of Endometriosis Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Endometriosis Market Analysis
Global Endometriosis Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Endometriosis Industry growth. Endometriosis market has been segmented with the help of its Type, Distribution Channel Treatment, and others. Endometriosis market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Report scope is customizable as we have a huge database of Endometriosis industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Major Type Analysed | |
Major Distribution Channel Analysed | |
Major Treatment Analysed | NSAIDs, Oral Contraceptive, Gonadotropin Releasing Hormone, Others |
Top Manufacturers Disclosed | |
Global, Regional and Country Analysis |
|
Key Qualitative Information Covered |
|
By Type, the Superficial Peritoneal Lesion segment holds the major revenue of Endometriosis Market!
The superficial peritoneal lesion segment has the largest revenue share in the endometriosis market. This is attributed to the rising prevalence of superficial peritoneal lesions and awareness about endometriosis is expected to drive the growth of the superficial peritoneal lesion segment.
- Superficial Peritoneal Lesion
- Endometrioma
- Deeply Infiltrating Endometriosis
- Others
Endometriosis Market Share (%) by Type in 2018-2030
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Endometriosis Industry. Request a Free Sample PDF!
By Distribution Channel of Endometriosis, Hospital pharmacy holds the major revenue share!
The hospital pharmacy segment has the largest revenue share in the endometriosis market. This is due to rising patients’ trust in hospitals as high-quality services and the number of hospital pharmacies is likely to the growth of the hospital pharmacy segment.
- Hospital pharmacy
- Retail pharmacy
- Others
Endometriosis Market Share (%) by Distribution Channel in 2018-2030
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Endometriosis market report 2023 Edition by contacting our team.
Endometriosis Treatment Segment Analysis
The oral contraceptives segment holds the major revenue share in terms of treatment
The oral contraceptives segment has the largest revenue share in the endometriosis market. This is due to increasing cases of menstrual problems and the adoption of oral contraceptives.
- NSAIDs
- Oral Contraceptive
- Gonadotropin Releasing Hormone
- Others
The North America Endometriosis Market dominates overall market:
North America has the largest revenue share in the endometriosis market. This is due to the increasing presence of several key players and the advancement in manufacturing technology of medicines anticipated to drive the growth of the endometriosis market in the region.
Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Endometriosis Market Share (%) by Region (2018-2030)
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
Endometriosis Industry News:
In January 2022, ObsEva has announced a positive topline for Linzagolix 200 mg with add-back therapy in the Phase 3 EDELWEISS 3 trial in women with moderate-to-severe endometriosis-associated pain.
Top Companies Market Share in Endometriosis Industry: (In no particular order of Rank)
- AbbVie
- AstraZeneca
- Bayer HealthCare
- Pfizer
- Addex Therapeutics
- Astellas Pharma
- Debiopharm
- ElexoPharm
- EndoCeutics
- Euroscreen
- Forendo Pharma
- Kissei Pharmaceutical
- Neurocrine Biosciences
- Nippon Shinyaku
- Takeda
- Bayer AG
- Neurocrine Biosciences
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Endometriosis Market is witnessing significant growth in the near future.
In 2022, the Superficial Peritoneal Lesion segment accounted for noticeable share of global Endometriosis Market and is projected to experience significant growth in the near future.
The Hospital pharmacy segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies AbbVie, Bayer HealthCare and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Author's Detail
David Fuller, LinkedIn
Senior Analyst at Cognitive Market Research
I am working as a Senior Analyst with Cognitive Market Research in the areas of Industry Survey and Market Research/Analytics. I collaborate with CXOs, VPs, and other senior executives to understand their data needs and provide solutions and business strategy building.
Key Questions Answered By Endometriosis Market Report 2023
Why Superficial Peritoneal Lesion have a significant impact on Endometriosis market? |
What are the key factors affecting the Superficial Peritoneal Lesion and Endometrioma of Endometriosis Market? |
What is the CAGR/Growth Rate of Hospital pharmacy during the forecast period? |
By type, which segment accounted for largest share of the global Endometriosis Market? |
Which region is expected to dominate the global Endometriosis Market within the forecast period? |
Frequently Asked Questions
Related Reports
- Measures to Explore Untapped Market
- Understanding Market Dynamics
- Understanding Changing Economics
- Competitors Market Share
- Global/Region/Country Level Analysis
- Identify Upcoming End Use Industries
- Global Price Trend Analysis
- Value Chain Analysis
- Customer Sentiment/Need Analysis
- Identification of Key Growth Segments
- Industry Upstream and Downstream Analysis
- Raw Material Sourcing and Cost Analysis
- Identify Key Customers Across Globe
- Concept Development and Market Testing
- Merger-Acquisition Strategy
- The research study and report are been made exclusively for an institution or person who is strategizing to build a business or strategically wants to expand certain portfolio.
- This report will help in analyzing complete market scenario across the globe who wish to expand their current business or is willing to invest in some profitable sector.
- This report will prove beneficial for person or an organization who wish to be updated regarding their business environment, consumers’ behaviour, and their requirements. The environment is constantly changing, and in such scenario, this report will help in understanding market parameters through 360-degree view.
- The report is thus ideal for KOL, CEO's, CFO's, directors, and others. It is also helpful to senior executives, business development managers, marketing managers, and consultants. Furthermore, government bodies, agencies and other kind of organizations can also leverage our report to understand market.
- Our objective for the Endometriosis market is to help in making imperative business decisions, securing investments, determining new business opportunities in the market. Further, the report helps to analyze overall marketing needs of customers, and avoid business failures.
- To know the potential market size and growth rate before launching a new product line. The report in a way helps in designing R&D budget wisely by estimating maximum total profit.
- To identify the Endometriosis market dynamics, industrial insights, and economic progression for critical information about the market conditions and specific business landscape.
- To assess the overall competitive landscape of a particular business sector and to provide complete analysis in regards with various external factors impacting the market growth.
- To create a strong foundation for building a strategy and foster insight into market conditions so that market players can make better business decisions. Besides, we aim to provide a complete portfolio of the major players involved the market.
- To define the scope which will further help in creating new products that will surpass the gap between current offerings and customers’ needs.
- To help in revealing significant clues concerning buying habits, regional culture, lifestyle, and population density that plays an integral role in shaping market behavior.
- To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the total market.
- Competitors Analysis: We provide data from the supplier side covering key details such as market share split among 1st tier, 2nd tier, and 3rd tier, Emerging Players, and Start-Ups. (whereas most of our competitors published data for top-tier companies)
- We provide market revenue share not only for Public listed companies but also the privately listed companies.
- Country Analysis: The Country level market split analysis is part of the report hence the data granularity is provided.
- We have been closely working with the Top 500 Fortune businesses, our clientele spanning 20+ industries. Our clientele is a mix of investors, manufacturers, end-users, distributors, etc. With our data subscription model (Athenaeum) 70% of clients have already subscribed/purchased reports for multiple years which helped us achieve unbelievable client retention statistics.
- Product + Service: In terms of the product we deliver the report access (PDF+ PPT+ EXCEL+ Cloud+ POWER BI) whereas in terms of service; we provide data support where a dedicated research analyst will be assigned and add-on benefits. (Whereas most of our competitors believe only in delivering the data/report and service and support remain questionable.)
- Credibility and Data Accuracy: We deliver accuracy close to 90-95% with the help of our in-house research team, freelancer, and industry expert network, sources present worldwide. This Data is backed up by strong What are our clients saying about our services.
Read more